We are live on ! Find out more
ACERW

Acer Therapeutics Inc Warrant
ACERW

Delisted

ACERW was delisted on the 5th of April, 2018.

Back to rankings

5 hedge funds and large institutions have $86K invested in Acer Therapeutics Inc Warrant in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$37.4K
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$24.7K
3
California Public Employees Retirement System
California Public Employees Retirement System
California
+$21.9K
4
UBS Group
UBS Group
Switzerland
+$4.52K
5
TSS
Two Sigma Securities
New York
+$3.06K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$35K +$37.4K +455,053 New
Bank of New York Mellon
2
Bank of New York Mellon
New York
$23K +$24.7K +299,985 New
California Public Employees Retirement System
3
California Public Employees Retirement System
California
$21K +$21.9K +266,050 New
UBS Group
4
UBS Group
Switzerland
$4K +$4.52K +54,978 New
TSS
5
Two Sigma Securities
New York
$3K +$3.06K +37,284 New

ACERW Hedge Fund Activity: Q3 2017 in Review

5 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc Warrant (ACERW) for Q3 2017, worth a combined $86K.

Buyers outnumbered sellers: 5 funds opened new ACERW positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $37.4K.

  • 5 institutional investors held Acer Therapeutics Inc Warrant (ACERW) as of Q3 2017, up from 0 in Q2 2017.
  • Funds reported $86K of Acer Therapeutics Inc Warrant stock for Q3 2017.
  • 5 funds opened new Acer Therapeutics Inc Warrant positions in Q3 2017 and 0 closed out, a net change of +5 holders.
  • The largest Acer Therapeutics Inc Warrant buyer in Q3 2017 was Virtu Financial, an estimated $37.4K added.

Based on aggregated 13F filings for Q3 2017.